TD Securities upgraded shares of Vitalhub (TSE:VHI – Free Report) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.
Separately, Cormark boosted their target price on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research report on Wednesday, October 2nd.
View Our Latest Analysis on Vitalhub
Vitalhub Trading Up 0.6 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The 3 Best Retail Stocks to Shop for in August
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.